68 related articles for article (PubMed ID: 1963777)
1. Equilibrium kinetics model for the cGMP-stimulated phosphodiesterase of brain coated vesicles.
Silva WI; Puszkin S
Bol Asoc Med P R; 1990 Sep; 82(9):407-11. PubMed ID: 1963777
[TBL] [Abstract][Full Text] [Related]
2. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites.
Erneux C; Couchie D; Dumont JE; Jastorff B
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():107-18. PubMed ID: 6326517
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
Gillespie PG; Beavo JA
Mol Pharmacol; 1989 Nov; 36(5):773-81. PubMed ID: 2555675
[TBL] [Abstract][Full Text] [Related]
5. [cGMP-dependent cyclic nucleotide phosphodiesterase from human lymphoid cells].
Azhaeva EV; Severin SE; Kondrat'ev AD
Biokhimiia; 1987 Nov; 52(11):1781-5. PubMed ID: 2830912
[TBL] [Abstract][Full Text] [Related]
6. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
[TBL] [Abstract][Full Text] [Related]
7. The binding of cyclic nucleotide analogs to a purified cyclic GMP-stimulated phosphodiesterase from bovine adrenal tissue.
Erneux C; Miot F; Van Haastert PJ; Jastorff B
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):463-72. PubMed ID: 2999203
[TBL] [Abstract][Full Text] [Related]
8. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
Grewal J; Karuppiah N; Mutus B
Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
[TBL] [Abstract][Full Text] [Related]
9. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the soluble fraction of the human brain: Kinetic properties and the effect of the antidepressant pyrazidol and its nitro analog on the enzyme].
Medvedeva MV; Belov AA; Kireeva NN; Bobruskin ID
Biokhimiia; 1993 May; 58(5):798-808. PubMed ID: 8393348
[TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
Rybalkin SD; Yan C; Bornfeldt KE; Beavo JA
Circ Res; 2003 Aug; 93(4):280-91. PubMed ID: 12933699
[TBL] [Abstract][Full Text] [Related]
11. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity.
Galoyan AA; Gurvitz BYa
Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614
[TBL] [Abstract][Full Text] [Related]
12. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
[TBL] [Abstract][Full Text] [Related]
13. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
14. Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity.
Turko IV; Francis SH; Corbin JD
Biochemistry; 1998 Mar; 37(12):4200-5. PubMed ID: 9521742
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ induces an increase in cGMP-phosphodiesterase activity in squid retinal photoreceptors.
Brown JE; Kelman ES
Biochem Biophys Res Commun; 1996 Jul; 224(3):684-9. PubMed ID: 8713107
[TBL] [Abstract][Full Text] [Related]
16. Effects of pH on allosteric and catalytic properties of the guanosine cyclic 3',5'-phosphate stimulated cyclic nucleotide phosphodiesterase from calf liver.
Wada H; Osborne JC; Manganiello VC
Biochemistry; 1987 Oct; 26(20):6565-70. PubMed ID: 2447936
[TBL] [Abstract][Full Text] [Related]
17. Characterization of nitric oxide synthase, soluble guanylyl cyclase, and Ca2+/calmodulin-stimulated cGMP phosphodiesterase as components of neuronal signal transduction.
Mayer B; Koesling D; Böhme E
Adv Second Messenger Phosphoprotein Res; 1993; 28():111-9. PubMed ID: 7691122
[No Abstract] [Full Text] [Related]
18. Cyclic-GMP-regulated enzymes and their possible physiological functions.
Walter U
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():249-58. PubMed ID: 6145321
[No Abstract] [Full Text] [Related]
19. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
20. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]